Comparative Study of Helicobacter pylori Eradication Rates of Twice‐Versus Four‐Times‐Daily Amoxicillin Administered with Proton Pump lnhibitor and Clarithromycin: A Randomized Study
- 8 July 2008
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 13 (4), 282-287
- https://doi.org/10.1111/j.1523-5378.2008.00615.x
Abstract
Proton pump inhibitor (PPI)-containing triple therapy with clarithromycin and amoxicillin is now a standard regimen for Helicobacter pylori eradication in Korea. Amoxicillin has time-dependent bactericidal activity against H. pylori; we therefore assumed a dosing schedule of amoxicillin would affect the eradication rate of H. pylori. The purpose of this study was to evaluate and compare the efficacy of different amoxicillin dosing schedules for the eradication of H. pylori. One hundred and eighty-six patients with H. pylori infection were eligible for this study. Patients were randomly assigned to one of two regimens: amoxicillin 1000 mg with clarithromycin 500 mg and omeprazole 20 mg twice daily for 2 weeks (BID group, n = 93), or amoxicillin 500 mg four times daily with clarithromycin 500 mg and omeprazole 20 mg twice daily for 2 weeks (QID group, n = 93). The success of H. pylori eradication was evaluated 4-5 weeks after completing treatment. Overall eradication rate was 90.3%, and eradication rates were 91.4% in the BID group and 89.2% in the QID group (p = 0.62). Compliances was 95.7% in the BID group and 93.5% in the QID group (p = 0.516); this was the only factor that significantly affected H. pylori eradication in this study. Side effects in both groups were generally mild. Amoxicillin regimens with PPI and clarithromycin are found to be equally effective and safe in both the BID and QID groups for H. pylori eradication. Therefore, considering patient's comfort, we recommend a twice daily amoxicillin regimen.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of 7‐day and 14‐day Proton Pump Inhibitor‐Containing Triple Therapy for Helicobacter pylori Eradication: Neither Treatment Duration Provides Acceptable Eradication Rate in KoreaHelicobacter, 2007
- Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South KoreaAntimicrobial Agents and Chemotherapy, 2004
- Treatment of Helicobacter pylori infection and factors influencing eradicationAlimentary Pharmacology & Therapeutics, 2002
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- Continuous Infusion of ??-Lactam AntibioticsClinical Pharmacokinetics, 1998
- Should continuous infusion of β‐lactam antibiotics be the first‐line approach?Journal of Clinical Pharmacy & Therapeutics, 1997
- The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infectionJournal of Antimicrobial Chemotherapy, 1997
- Is continuous infusion of β-lactam antibiotics worthwhile?—efficacy and pharmacokinetic considerationsJournal of Antimicrobial Chemotherapy, 1996
- The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer DiseaseNew England Journal of Medicine, 1995
- Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal UlcerAnnals of Internal Medicine, 1992